TABLE 1—
Male-to-Female Transgender Persons | Control Group | P | |
Demographics | |||
Recruitment site,a % | |||
Los Angeles, Calif | 29 | 29 | |
San Francisco, Calif | 48 | 48 | |
New York, NY | 17 | 17 | |
Milwaukee, Wis | 7 | 7 | |
Age, mean, y (SD; range = 17–68) | 38.8 (6.8) | 41.5 (7.2) | .009 |
Education, mean, y (SD; range = 0–18) | 11.7 (1.9) | 12.5 (2.4) | .008 |
Ethnicity, % | |||
African American | 66 | 40 | <.001 |
Latino | 15 | 18 | NS |
White | 9 | 35 | <.001 |
Other | 10 | 7 | NS |
Living in welfare hotel or shelter, % | 32 | 12 | <.001 |
History of incarceration, % | 81 | 51 | <.001 |
Daily alcohol use, past 3 mo, % | 19 | 6 | .002 |
Injection drug use, past year, % | 21 | 15 | NS |
Health status | |||
Most recent CD4 cell count, mean, mm3 (SD; range = 0–1906) | 436 (319) | 426 (292) | NS |
Detectable viral load (self-report), % | 65 | 58 | NS |
No. of AIDS-related symptoms, mean (SD; range = 0–25) | 12.1 (0.76) | 12.4 (0.34) | NS |
Beck Depression Inventory, mean score (SD; range = 0–63) | 12.9 (8.9) | 13.0 (9) | NS |
State-Trait Anxiety Inventory, mean score (SD; range = 20–80) | 34.1 (10.7) | 36.1 (10.5) | NS |
Health services | |||
No. of visits to primary care provider, past 3 mo, mean (SD; range=0–24) | 3.9 (2.7) | 3.4 (3.3) | NS |
Health insurance coverage, % | 32 | 32 | NS |
Currently taking highly active antiretroviral therapy, % | 59 | 82 | <.001 |
Note. NS = results that were not statistically significant.
a Site of recruitment was used to match the control group to male-to-female transgender persons.